Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioRestorative Therapies ...

    NASDAQ: BRTX · Real-Time Price · USD
    1.77
    -0.01 (-0.57%)
    At close: Jun 06, 2025, 3:35 PM
    1.85
    4.52%
    After-hours: Jun 06, 2025, 04:09 PM EDT

    BioRestorative Therapies Statistics

    Share Statistics

    BioRestorative Therapies has 7.5M shares outstanding. The number of shares has increased by 2.22% in one year.

    Shares Outstanding

    n/a
    		 7.5M

    Shares Change (YoY)

    n/a
    		 2.22%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 3.47%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,731

    FTD / Avg. Volume

    n/a
    		 7.78%

    Short Selling Information

    The latest short interest is 163.3K, so 2.18% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 163.3K

    Short % of Shares Out

    n/a
    		 2.18%

    Short % of Float

    n/a
    		 2.62%

    Short Ratio (days to cover)

    n/a
    		 5.61

    Valuation Ratios

    The PE ratio is -1.24 and the forward PE ratio is -1.63. BioRestorative Therapies's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.24

    Forward PE

    n/a
    		 -1.63

    PS Ratio

    n/a
    		 27.69

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 1.3

    P/FCF Ratio

    n/a
    		 -1.33

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioRestorative Therapies.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.97

    Quick Ratio

    n/a
    		 2.97

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $36,454.55

    Profits Per Employee

    n/a
    		 $-816,307.36

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 51.69% in the last 52 weeks. The beta is 0.36, so BioRestorative Therapies's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.36

    52-Week Price Change

    n/a
    		 51.69%

    50-Day Moving Average

    n/a
    		 1.75

    200-Day Moving Average

    n/a
    		 1.72

    Relative Strength Index (RSI)

    n/a
    		 54.7

    Average Volume (20 Days)

    n/a
    		 35,098

    Income Statement

    In the last 12 months, BioRestorative Therapies had revenue of 401K and earned -8.98M in profits. Earnings per share was -1.16.

    Revenue

    n/a
    		 401K

    Gross Profit

    n/a
    		 372.93K

    Operating Income

    n/a
    		 -11.56M

    Net Income

    n/a
    		 -8.98M

    EBITDA

    n/a
    		 -11.37M

    EBIT

    n/a
    		 -11.56M

    Earnings Per Share (EPS)

    n/a
    		 -1.16
    Full Income Statement

    Balance Sheet

    The company has 547.89K in cash and 0 in debt, giving a net cash position of 547.89K.

    Cash & Cash Equivalents

    n/a
    		 547.89K

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -155.68M

    Total Assets

    n/a
    		 10.33M

    Working Capital

    n/a
    		 5.17M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.23M and capital expenditures -106.19K, giving a free cash flow of -8.34M.

    Operating Cash Flow

    n/a
    		 -8.23M

    Capital Expenditures

    n/a
    		 -106.19K

    Free Cash Flow

    n/a
    		 -8.34M

    FCF Per Share

    n/a
    		 -1.07
    Full Cash Flow Statement

    Margins

    Gross margin is 93%, with operating and profit margins of -2881.59% and -2239.25%.

    Gross Margin

    n/a
    		 93%

    Operating Margin

    n/a
    		 -2881.59%

    Pretax Margin

    n/a
    		 -2239.25%

    Profit Margin

    n/a
    		 -2239.25%

    EBITDA Margin

    n/a
    		 -2834.45%

    EBIT Margin

    n/a
    		 -2881.59%

    FCF Margin

    n/a
    		 -2078.94%

    Dividends & Yields

    BRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BRTX is $18, which is 905.6% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $18

    Price Target Difference

    n/a
    		 905.6%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 27, 2021. It was a backward split with a ratio of 1:4000.

    Last Split Date

    n/a
    		 Oct 27, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4000

    Scores

    Altman Z-Score

    n/a
    		 -23.21

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist